title: Radical Oncological Surgery and Adjuvan Therapy in Non- Small Cell Lung Cancer Patients over 70 years of Age.
abstract: BACKGROUND
  The incidence of lung cancer increases with age. Approximately 50% of non-small cell lung cancer (NSCLC) patients are over 70 years old. Because of the increasing elderly population, treatment approaches in this age group continue to be studied similar to groups of young people.
  
  
  METHODS
  In the current study, 26 patients who underwent radical surgery and adjuvan chemoradiation at Ataturk Chest Diseases and Chest Surgery Training and Research Hospital were evaluated retrospectively.
  
  
  RESULTS
  Of 21 patients (81%) were male and the average age was 74.4. Lobectomy was performed in 18 cases, pneumonectomy in 3, sleeve lobectomy in 3 and bilobectomy in 2. There was no perioperative or early period mortality. Overall survival was 24.5 months.
  
  
  CONCLUSIONS
  From our study, lung cancer surgery and adjuvant therapy can be performed safely with low morbidity in the elderly.
authors.affiliation: Gazi University, Faculty of Medicine Chest Disease Department, Ankara Turkey E-mail : nilgundemirci@gmail.com.
authors.forename: Nilgun Yilmaz
authors.initials: NY
authors.lastname: Demirci
authors.forename: Sukran
authors.initials: S
authors.lastname: Ulger
authors.forename: Ulku
authors.initials: U
authors.lastname: Yilmaz
authors.forename: Koray
authors.initials: K
authors.lastname: Aydogdu
authors.forename: Aydin
authors.initials: A
authors.lastname: Yilmaz
authors.forename: Yurdanur
authors.initials: Y
authors.lastname: Erdogan
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D059186:Chemoradiotherapy, Adjuvant / Q000401:mortality*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000401:mortality*; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate